secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0000950170-25-055927
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya receives Nasdaq bid price deficiency notice; must regain compliance by Oct 13, 2025
--------------------------------------------------------------------------------

- Closing bid price of TNYA common stock below $1.00 for 30 consecutive business days through April 12, 2025.
- Nasdaq granted 180-day compliance period ending October 13, 2025; no immediate impact on listing.
- To regain compliance, shares must close at $1.00 or higher for at least 10 consecutive business days.
- If not cured, Company may seek a second 180-day period by transferring to Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/0000950170-25-055927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025055927/tnya-20250415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-055927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer